These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3152121)

  • 1. [Problems of the development of microbial drug resistance].
    Nihon Rinsho; 1988 Jul; 46 Suppl():179-273. PubMed ID: 3152121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic resistance in Pseudomonas aeruginosa, Hemophilus influenzae, and Staphylococcus aureus.
    van Klingeren B
    Chest; 1988 Aug; 94(2 Suppl):103S-109S. PubMed ID: 3135158
    [No Abstract]   [Full Text] [Related]  

  • 4. To the editor: effect of anesthetic gases on the growth of Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus.
    A-Rahman A; Pedler S; Bray R; O'Brien CJ
    Pediatr Pulmonol; 2002 Sep; 34(3):226-7. PubMed ID: 12203853
    [No Abstract]   [Full Text] [Related]  

  • 5. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 6. To the editor: Re: A-Rahman, Pedler S, Bray R, The effect of anesthetic gases on the growth of Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus, Pediatr Pulmonol 2002;34:226-227.
    Kerr JR
    Pediatr Pulmonol; 2003 May; 35(5):414; author reply 415. PubMed ID: 12687602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
    Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The extent of resistance on clinically important pathogens in the Federal Republic].
    Pulverer G
    Adv Clin Pharmacol; 1974; 8():21-32. PubMed ID: 4157112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity of strains resistant to tetracycline].
    Frottier J
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):116-8. PubMed ID: 6965533
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of multiple-resistant bacteria].
    Lucet JC
    Rev Prat; 1998 Sep; 48(14):1541-6. PubMed ID: 9814049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MRSA in bacterial infections].
    Hara K; Kaku M
    Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1583-5. PubMed ID: 1469305
    [No Abstract]   [Full Text] [Related]  

  • 14. The emergence of antimicrobial resistance in New Zealand.
    Green MJ
    N Z Med J; 1979 Apr; 89(634):314-6. PubMed ID: 109800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriological studies in chronic otitis media].
    Swiderski M
    Wiad Lek; 1983 Feb; 36(4):273-7. PubMed ID: 6407211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of bacterial resistance to antibiotics and chemotherapeutic drugs and a tendency towards the development of resistance].
    Fritsche D; Schulz-Stübner A
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1963-8. PubMed ID: 4404874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
    Beeuwkes H; Buytendijk HJ; Maesen FP
    Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiresistant bacteria in dermatology].
    Lucet JC
    Ann Dermatol Venereol; 1998 Oct; 125(10):669-71. PubMed ID: 9835952
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the effectiveness of new quaternary ammonium salts against selected strains of bacteria and fungi. Sensitivity of microbial strains isolated from patients to various ammonium salts].
    Pernak J; Kucharski S
    Acta Pol Pharm; 1979; 36(3):377-82. PubMed ID: 117676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.